ABSTRACT
Due to the possible negative effects on both the mother and the foetus, co-infection with syphilis, hepatitis C virus (HCV), and Helicobacter pylori (H. pylori) in pregnant women is a serious public health problem. In this study, pregnant patients at the Mbodo Health Centre in Aluu, Port Harcourt, Rivers State, were asked to rate their prevalence of co-infection and related risk factors. 96 willing pregnant women gave consent for blood samples to be drawn, and ELISA and fast diagnostic kits were used to test the sera for Helicobacter pylori, hepatitis C, and syphilis. Results showed that 31.0% of the pregnant women had Helicobacter pylori, but none had positive results for syphilis or the hepatitis C virus. The highest prevalence of H. pylori infection, as determined by ELISA, was observed in the age group 30-39 years (37.5%), married groups (32.7%), secondary school education (44.0%), students (40.0%), and Christian religion (31.3%). This finding demonstrated that H. pylori was more common in the study area than the other two pathogens. Pregnant women visiting the Primary Health Centre, Mbodo-Aluu, Rivers State had significant rates of H. pylori infection with no coinfection with HCV and syphilis. This study emphasises the necessity of integrated screening and treatment initiatives during antenatal care. However, preventing unfavourable pregnancy outcomes and lowering the risk of vertical transmission to the baby need the early detection and treatment of these pathogens. Therefore, it is important to emphasise good knowledge and education about the infection in this area.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Port Harcourt Research Ethics Committee and University of Port Harcourt Teaching Hospital Research Ethics Committee gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
